Afficher la notice abrégée
dc.contributor.author |
HAMIDA, ASMA |
|
dc.contributor.author |
AZREUG, SOUMIA |
|
dc.date.accessioned |
2018-11-28T13:25:16Z |
|
dc.date.available |
2018-11-28T13:25:16Z |
|
dc.date.issued |
2017 |
|
dc.identifier.uri |
http://e-biblio.univ-mosta.dz/handle/123456789/3411 |
|
dc.description.abstract |
Diabetes is the leading cause of chronic renal failure (CKD) in early stages,
nephroprotective therapies associated with glycemic control and lifestyle changes are
recommended, but at the end-stage survival is ensured by A supportive treatment: dialysis or
renal transplantation.
IRC leading to terminal renal failure requiring dialysis or transplantation is a major
public health problem. It is therefore important to identify an IRC at an early stage in order to
slow down its progression and reduce its consequences. These consequences must be known
because their adequate management reduces the associated morbidity: anemia, hyperkalaemia,
water overload, the hypernatremia.
Hemodialysis is a treatment (HD) meets a vital need for uremic patients must enroll in a
comprehensive and long-term. It aims to correct metabolic disorders, ensure the survival of
patients. |
en_US |
dc.language.iso |
fr |
en_US |
dc.subject |
Keywords |
en_US |
dc.subject |
Diabetes |
en_US |
dc.subject |
Chronic renal insufficiency |
en_US |
dc.subject |
hemodialysis |
en_US |
dc.subject |
Diabète |
en_US |
dc.subject |
Insuffisance rénale chronique |
en_US |
dc.subject |
hémodialyse |
en_US |
dc.title |
Etude de l’insuffisance rénale chronique chez les diabétiques |
en_US |
dc.type |
Other |
en_US |
Fichier(s) constituant ce document
Ce document figure dans la(les) collection(s) suivante(s)
Afficher la notice abrégée